The Most Expensive Drugs in the U.S. According to GoodRx
GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare [...]
Proposed change to CMS Rules Aim Will Expand Access to High-cost Therapies for Medicaid Recipients
The Medicaid Best Price rule requires drug manufacturers to give Medicaid the best price on all purchases. However, the rule [...]
How COVID-19 Provides Opportunities to Implement Value-Based Care Practices
COVID-19 has drastically changed the healthcare landscape for payers and providers as telehealth services are increasingly utilized. Experts discussed how [...]
Webinar Recap: It’s Time to Talk About COVID-19 Prices
Join National Pharmaceutical Council Chief Science Officer Robert Dubois, Memorial Sloan Kettering Cancer Center's Peter Bach, Institute for Clinical and [...]
Value-based Models Achieve Better Patient Outcomes in Primary Care Practices
A new study from United Health Group shows that primary care physicians (PCPs) perform better on key quality metrics when [...]
How Effective is Precision Medicine in the Fight Against Lung Cancer?
Precision medicine, an approach that relies on drugs that target specific genes, has produced specular results by saving many individual [...]
Post-Pandemic Paradigm Shifts and New Dimensions of Value, a DIA DIRECT webinar
The current pandemic has forced us to recognize the weaknesses of our current social, economic, and healthcare systems and rethink [...]
BHE Rebrands Itself as Panalgo In Effort To Empower Pharma, Payers and Providers With Trusted Analytics.
BHE has rebranded itself as Panalgo to better expand access to reliable health analytics using their Instant Health Data (IHD) [...]
Toward A More Precise Public Health Strategy in the Battle Against COVID-19
COVID-19 is one of the greatest public health challenges ever to face United States with cases in excess of 5,000,000. [...]
New Roadmap Aims to Transform Healthcare Landscape by Minimizing Low Value Services
The COVID-19 pandemic is causing financial disruption and turbulence on an unprecedented scale raising further questions on how to best [...]
Germany’s Experiment With Drug Price Regulation: Aligning Clinical Benefit With Cost of Cancer Drugs
According to a new study, Germany’s move to reform pharmaceutical spending has resulted in closer alignment between clinical benefit and [...]
What a tangled web we weave: The complex relationship between PBMs and GPOs
Join Avalere Health principal Mike Schneider as he discusses why traditional Pharmacy Benefit Managers (PBMs) are deciding that now may [...]
Free Strategic Playbook Aims to Bring Cures to Patients More Efficiently
Harvard Business School’s Kraft Precision Medicine Accelerator announced the launch of a playbook specifically developed to bring vital assistance to [...]
Capping Out-of-Pocket Costs for Specialty Drugs Reduces Patient Spending By 32%
A recently published study in the New England Journal of Medicine found that capping out-of-pocket costs for specialty drugs resulted [...]
MMIT releases Special Report on Value Based Agreements (VBA’s) Between Payers and Manufacturers
A special report launched by MMIT aims to provide guidance on value-based contracting discussion with evidence-based insights. Some key highlights: [...]
Lilly + Prime Therapeutics Push the Envelope on Next Generation Value-based Agreements
Lilly has partnered with Prime Therapeutics to explore how value-based arrangements (VBA’s) can be used to improve patient outcomes while [...]
AMCP Collaborate Platform Enhances Collaboration to Support and Inform Managed Care Pharmacy
AMCP Collaborate is a platform for AMCP members to connect and share ideas and solutions about the most vexing challenges [...]
Health Economics & Outcomes Research (HEOR) Services Market Research Report 2020 Just Released
Intellectual Research Partners has released the Health Economics & Outcomes Research (HEOR) Services Market Research Report 2020.The report details the [...]
Optum leverages natural language processing system (NLP) to provide oncology- related insights
Making data available to researcher through extracting essential information from oncological medical records is one of Optum’s key oncology data [...]
Key Innovations Coming From The Next Generation of PBM’s
The world of pharmacy benefit management (PBM) will change dramatically over the next five years and much of the change is coming from [...]
What Does $11M in Donations to Congress Buy Pharma?
Pharmaceutical manufacturers and trade groups have recently contributed $11 million and cut 4,500 checks to Congressional lawmakers ahead of the [...]
Eversana Partners on Research Data Assessment
Eversana, a global life-sciences commercial services firm, is partnering with the Institute for Clinical and Economic Review (ICER) to promote [...]
Stanford Center for Health Education Launches Online Program in AI and Healthcare.
A new program launched by the Stanford Center for Health Education aims to advance the delivery of patient care and [...]
PRMA Consulting Announces New Singapore Office and Virtual Open House
Jayne Sykes, Partner at PRMA Consulting, announces a new office opening in Singapore and explains how the company is shaping [...]
OM1 Insights: How We Use AI to Find Rare Disease Patients
"Correctly identifying a patient with a rare disease can be like looking for a needle in a haystack", according to [...]